[go: up one dir, main page]

PT1214097E - Ácidos nucleicos que codificam polipéptidos de poliepitopos - Google Patents

Ácidos nucleicos que codificam polipéptidos de poliepitopos Download PDF

Info

Publication number
PT1214097E
PT1214097E PT00965119T PT00965119T PT1214097E PT 1214097 E PT1214097 E PT 1214097E PT 00965119 T PT00965119 T PT 00965119T PT 00965119 T PT00965119 T PT 00965119T PT 1214097 E PT1214097 E PT 1214097E
Authority
PT
Portugal
Prior art keywords
nucleic acids
acids encoding
polyepitope polypeptides
encoding polyepitope
polypeptides
Prior art date
Application number
PT00965119T
Other languages
English (en)
Inventor
Mary Lynne Hedley
Robert C Urban
Roman M Chicz
Original Assignee
Eisai Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Inc filed Critical Eisai Inc
Publication of PT1214097E publication Critical patent/PT1214097E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00965119T 1999-09-16 2000-09-18 Ácidos nucleicos que codificam polipéptidos de poliepitopos PT1214097E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15466599P 1999-09-16 1999-09-16
US39853499A 1999-09-16 1999-09-16
US45817399A 1999-12-09 1999-12-09
US16984699P 1999-12-09 1999-12-09

Publications (1)

Publication Number Publication Date
PT1214097E true PT1214097E (pt) 2009-10-19

Family

ID=27496146

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00965119T PT1214097E (pt) 1999-09-16 2000-09-18 Ácidos nucleicos que codificam polipéptidos de poliepitopos

Country Status (10)

Country Link
EP (2) EP2100620A1 (pt)
JP (1) JP2003509035A (pt)
AU (1) AU785319B2 (pt)
CA (1) CA2384987A1 (pt)
CY (1) CY1109699T1 (pt)
DE (1) DE60042556D1 (pt)
DK (1) DK1214097T3 (pt)
ES (1) ES2330078T3 (pt)
PT (1) PT1214097E (pt)
WO (1) WO2001019408A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781951B2 (en) * 2000-02-02 2005-06-23 Transgene S.A. Targeting peptides
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
ATE494387T1 (de) 2001-11-07 2011-01-15 Mannkind Corp Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
WO2003095642A2 (en) * 2002-05-07 2003-11-20 Aventis Pasteur, Ltd. Polyepitopes and mini-genes for cancer treatment
AU2002950183A0 (en) * 2002-07-12 2002-09-12 The Council Of The Queensland Institute Of Medical Research Expression of hydrophobic proteins
ATE465753T1 (de) * 2002-10-21 2010-05-15 Eisai Inc Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
CA2519025A1 (en) 2003-03-28 2004-10-07 The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services, Centers For Disea Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use
NZ544011A (en) * 2003-06-10 2009-02-28 Univ Melbourne Immunomodulating compositions uses therefor and processes for their production
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
JP5971945B2 (ja) 2008-04-17 2016-08-17 ピーディーエス バイオテクノロジー コーポレイションＰｄｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ カチオン性脂質の鏡像異性体による免疫応答の刺激
US20130011424A1 (en) * 2010-03-09 2013-01-10 Timur ARTEMEV Polyepitope constructs and methods for their preparation and use
CN105463001A (zh) * 2010-08-13 2016-04-06 株式会社吉耐森 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物
EP2604629B1 (en) 2010-08-13 2018-02-28 Genexine, Inc. Composition for preventing or treating cervical cancer having human papillomavirus immunity enhancer
CN105463000B (zh) * 2010-08-13 2021-06-01 株式会社吉耐森 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物
EP3473267B1 (en) 2011-05-24 2021-09-08 BioNTech RNA Pharmaceuticals GmbH Individualized vaccines for cancer
RU2670745C9 (ru) 2011-05-24 2018-12-13 Бионтех Рна Фармасьютикалс Гмбх Индивидуализированные противоопухолевые вакцины
KR20150058139A (ko) 2012-06-15 2015-05-28 피디에스 바이오테크놀러지 코퍼레이션 양이온성 지질 백신 조성물 및 이용 방법
WO2014047533A1 (en) 2012-09-21 2014-03-27 Frank Bedu-Addo Improved vaccine compositions and methods of use
MX2017002081A (es) 2014-08-15 2017-05-23 Genexine Inc Metodo para tratar cancer de cuello uterino.
AU2015341926B2 (en) * 2014-11-04 2018-09-27 Janssen Vaccines & Prevention B.V. Therapeutic HPV16 vaccines
US11612652B2 (en) 2015-11-13 2023-03-28 Pds Biotechnology Corporation Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
EP3386593A4 (en) * 2015-12-09 2019-07-24 Admedus Vaccines Pty Ltd IMMUNOMODULATING COMPOSITION FOR TREATMENT
CN110035765B (zh) 2016-10-05 2024-04-02 Pds生物科技公司 新型hpv16非hla限制性t细胞疫苗、组合物及其使用方法
AU2017386682A1 (en) * 2016-12-28 2019-07-25 Invvax, Inc. Influenza vaccines
CN111093691A (zh) * 2017-04-03 2020-05-01 内恩疗法公司 蛋白质抗原及其用途
WO2018224166A1 (en) 2017-06-09 2018-12-13 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
WO2020072371A1 (en) * 2018-10-01 2020-04-09 The Wistar Institute Melanoma canine vaccine compositions and methods of use thereof
CA3147874A1 (en) * 2019-07-19 2021-01-28 The General Hospital Corporation Self-assembled vaccines and combination therapies for treating cancer
IL297502A (en) 2020-04-24 2022-12-01 Genexine Inc A method for treating cervical cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
PT97073A (pt) * 1990-03-20 1991-10-31 Behringwerke Ag Processo para a preparacao de epitopos soro-reactivos de proteinas de papillomavirus 16 humano (hpv)
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
US5753233A (en) * 1990-05-10 1998-05-19 Behring Diagnostics Gmbh Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
AU8762991A (en) * 1990-09-26 1992-04-15 Bristol-Myers Squibb Company Human papilloma viral protein expression for use in vaccine compositions
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
EP0523391B1 (en) * 1991-07-13 2003-03-19 Dade Behring Marburg GmbH Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose
IL105554A (en) * 1992-05-05 1999-08-17 Univ Leiden Peptides of human papillomavirus for use in preparations elicit a human T cell response
EP0671926B1 (en) 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunomodulatory peptides
US5679509A (en) * 1993-09-28 1997-10-21 University Of New Mexico Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer
CA2190121A1 (en) 1994-03-15 1995-09-21 Edith Mathiowitz Polymeric gene delivery system
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
US5783567A (en) 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein

Also Published As

Publication number Publication date
JP2003509035A (ja) 2003-03-11
EP1214097B1 (en) 2009-07-15
EP1214097B9 (en) 2010-05-19
EP1214097A1 (en) 2002-06-19
AU785319B2 (en) 2007-01-11
WO2001019408A1 (en) 2001-03-22
EP1214097B3 (en) 2011-07-20
DK1214097T3 (da) 2009-11-16
WO2001019408A9 (en) 2002-12-05
ES2330078T3 (es) 2009-12-04
AU7589100A (en) 2001-04-17
EP2100620A1 (en) 2009-09-16
CA2384987A1 (en) 2001-03-22
CY1109699T1 (el) 2014-08-13
EP1214097A4 (en) 2005-02-02
DE60042556D1 (de) 2011-02-10

Similar Documents

Publication Publication Date Title
PT1214097E (pt) Ácidos nucleicos que codificam polipéptidos de poliepitopos
AU2001234944A8 (en) Novel nucleic acids and polypeptides
AU2001291649A1 (en) Nucleic acids encoding polypeptides having proteolytic activity
AU2001248284A1 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
AU2001246407A1 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
AU2001246405A1 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
AU2001246406A1 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
IL148843A0 (en) Immunostimulatory nucleic acids
IL145785A0 (en) Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
AU1181802A (en) Novel proteins and nucleic acids encoding same
AU8308901A (en) Novel proteins and nucleic acids encoding same
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
AU7005801A (en) Gp354 nucleic acids and polypeptides
AU1453601A (en) Novel polypeptides and nucleic acids encoding same
AU2001263005A8 (en) Novel nucleic acids and polypeptides
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same
AU3099402A (en) Novel proteins and nucleic acids encoding same
HUP0103361A2 (hu) VIII-as faktor homológ nukleinsavak, polipeptidek, módszerek, alkalmazások
AU4306401A (en) Dna encoding a novel prost-ets polypeptide
AU2002254427A1 (en) Nucleic acids encoding isav polypeptides
AU2002357163A8 (en) Apyrase polypeptides and nucleic acids encoding same
AU7298201A (en) Gp286 nucleic acids and polypeptides
EP1225220A4 (en) DNA encoding ENDO-BETA galactosidase
WO2002032961A8 (en) Novel polypeptides and nucleic acids encoding same
AU2001234627A1 (en) Novel polypeptides and nucleic acids encoding same